Helping Everyone Achieve a LifeTime of Health - Future Addiction Scientist Training

帮助每个人实现一生的健康——未来成瘾科学家培训

• 批准号: 10398253
• 负责人: Ezemenari M Obasi
• 金额: $ 20.24万
• 依托单位: UNIVERSITY OF HOUSTON
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-05-01 至 2026-01-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10398253
• 关键词: ATOD; Address; Affect; Applications Grants; Area; Asian; Asian Americans; Behavior; Behavioral Sciences; Biochemistry; Biology; Biomedical Engineering; Black race; Career Mobility; Chronic Disease; Clinical Sciences; Communities; Computers; Data; Degree program; Development; Development Plans; Educational Curriculum; Educational Status; Engineering; Enrollment; Ensure; Event; Evidence based intervention; Faculty; Feedback; Funding; Future; Future Generations; Grant; Health; Health Sciences; Health system; Hispanic-serving Institution; Human; Individual; Institution; Interdisciplinary Study; Investments; Journals; Knowledge; Latinx; Learning; Location; Manuscripts; Maps; Medical center; Mental Health; Mentors; Minority Women; Modification; National Institute of Drug Abuse; National Institute on Minority Health and Health Disparities; Native Americans; Outcome; Pacific Island Americans; Peer Review; Performance; Pharmaceutical Chemistry; Pharmaceutical Preparations; Pharmacologic Substance; Policies; Population; Population Sizes; Postdoctoral Fellow; Preparation; Process; Productivity; Program Evaluation; Program Reviews; Psychology; Public Health; Publications; Research; Research Activity; Research Institute; Research Personnel; Research Training; Resources; Risk; Science; Scientist; Secure; Series; Social Sciences; Social Work; Substance Addiction; Substance abuse problem; Texas; Time; Training; Training Programs; Training and Education; Underrepresented Populations; Universities; Work; Writing; addiction; alcohol tobacco and other drug use; cancer prevention; career; college; comorbidity; design; disadvantaged background; disease disparity; education research; ethnic diversity; experience; faculty mentor; faculty research; health disparity; health disparity populations; health equity; health science research; improved; innovation; meetings; metropolitan; next generation; novel; population health; programs; protective factors; racial and ethnic; responsible research conduct; skills; substance use; substance use prevention; trafficking; trend; vulnerable community

PROJECT SUMMARY/ABSTRACT The HEALTH Research Institute was established at UH to pursue a bold research agenda aimed at addressing the public health crises health disparities inflict on our most vulnerable communities. Investing in a new NIDA R25 at UH represents an excellent strategic investment in establishing a diverse pipeline of future substance abuse scientists given our: (1) central location in arguably the most ethnically diverse metropolitan area (~44% Latinx, ~26% White, ~23% Black, and ~7% Asian) in the U.S.; (2) one of the only Tier-1 research institutions with a Hispanic-Serving Institution (HSI) and Asian American and Native American Pacific Islander-Serving Institution (AANAPISI) designation; (3) ~400 health research faculty and 97 degree programs who will benefit from a research education program that focuses on substance abuse given Houston’s designation as a high-intensity drug trafficking area (HTDTA); and (4) the institutional investment in the HEALTH Research Institute which will house this proposed NIDA R25 to ensure it addresses substance abuse education and research training across the University and beyond. This HEALTH – Future Addiction Scientist Training (HEALTH-FAST) Program will focus on annually enrolling and advancing the careers of Doctoral (n=4), Postdoctoral (n=2), and Early Stage Investigators (ESI) Trainees (n=2) – with a total of 40 Trainees from underrepresented backgrounds in the health sciences across the 5-year funding period. This will be achieved by the successful completion of 4 specific aims: (1) Identify, select, educate, and mentor highly qualified Doctoral, Postdoctoral, and ESI Trainees from underrepresented groups in the health sciences for substance abuse research careers with an emphasis on linkages to ATOD-related chronic diseases and health disparities; (2) Develop a cutting-edge substance abuse research education curriculum that will include an array of diverse activities that are reflective of emerging national trends to facilitate an enriching educational experience; (3) Advance skills needed to effectively disseminate innovative scientific research at professional meetings and in peer-reviewed journals, while simultaneously accelerating Trainees’ competitiveness to secure NIDA grant funding; and (4) Systematically evaluate HEALTH-FAST processes, programming, and Trainee outcome data in real-time to demonstrate a NIDA return on investment and inform data-driven program modifications as needed. Given the proposed transdisciplinary approach to health-equity science, the HEALTH-FAST Program will leverage Program Faculty Mentors across 7 colleges and 12 academic units (i.e., Biomedical Engineering; Biomedical Sciences; Clinical Sciences; Electrical & Computer Engineering; Health & Human Performance; Health Systems & Population Health Sciences; Medicinal Chemistry; Pharmaceutical Health Outcomes and Policy; Psychological, Health, & Learning Sciences; Psychology; Biology & Biochemistry; and Social Work) to execute a cutting-edge research education program.

项目概要/摘要 健康研究所在夏威夷大学成立，旨在推行一项大胆的研究议程，旨在解决 公共卫生危机给我们最脆弱的社区带来健康差异 投资新的 NIDA。 休斯敦大学的 R25 代表了一项出色的战略投资，旨在建立未来物质的多样化管道 虐待科学家给出了我们的：（1）位于有争议的种族最多元化的大都市区的中心位置 （约 44% 拉丁裔、约 26% 白人、约 23% 黑人和约 7% 亚裔）在美国 (2) 唯一的一级研究之一； 设有西班牙裔服务机构 (HSI) 以及亚裔美国人和美洲原住民的机构 太平洋岛民服务机构 (AANAPISI) 称号 (3) 约 400 名健康研究人员和 97 个学位课程将从专注于药物滥用的研究教育计划中受益 鉴于休斯顿被指定为高强度贩毒区 (HTDTA)，以及 (4) 机构； 对健康研究所的投资，该研究所将容纳拟议的 NIDA R25，以确保其解决 整个大学内外的药物滥用教育和研究培训。这种健康——未来。 成瘾科学家培训（HEALTH-FAST）计划将侧重于每年招募和推进成瘾科学家培训（HEALTH-FAST）计划 博士 (n=4)、博士后 (n=2) 和早期研究人员 (ESI) 实习生 (n=2) 的职业生涯 – 具有 在为期 5 年的资助中，共有 40 名来自健康科学领域代表性不足的学员 这将通过成功完成 4 个具体目标来实现：(1) 识别、选择、教育和培训。 来自卫生领域代表性不足群体的高素质导师博士、博士后和 ESI 培训生 药物滥用研究职业科学，重点是与 ATOD 相关慢性疾病的联系 (2) 开发尖端的药物滥用研究教育课程， 包括一系列反映新兴国家趋势的多样化活动，以促进丰富 教育经验；(3) 有效传播创新科学研究所需的高级技能 专业会议和同行评审期刊，同时加速学员的 确保 NIDA 拨款资金的竞争力；以及 (4) 系统评估 HEALTH-FAST 流程， 实时编程和学员成果数据，以展示 NIDA 的投资回报并提供信息 根据需要对数据驱动的计划进行修改。 科学方面，HEALTH-FAST 计划将利用来自 7 个学院和 12 个学术机构的计划教师导师 单元（即生物医学工程；生物医学科学；临床科学；电气与计算机工程； 健康与人类表现；卫生系统与人口健康科学； 药物健康结果和政策；心理、健康和学习心理学； 和生物化学；和社会工作）执行尖端研究教育计划。